"Glycated Hemoglobin A" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Products of non-enzymatic reactions between GLUCOSE and HEMOGLOBIN A, occurring as a minor fraction of the hemoglobin components of human erythrocytes. Hemoglobin A1c is hemoglobin A with glucose covalently bound to the terminal VALINE of the beta chain. Glycated hemoglobin A is used as an index of the average blood sugar level over a lifetime of erythrocytes.
|Glycated Hemoglobin A
- Glycated Hemoglobin A
- Hemoglobin A, Glycated
- Hb A1a+b
- Hb A1c
- Glycosylated Hemoglobin A
- Hemoglobin A, Glycosylated
- Hb A1
- Glycohemoglobin A
- Hemoglobin A(1)
- Hb A1a-2
- Hemoglobin, Glycated A1a-2
- A1a-2 Hemoglobin, Glycated
- Glycated A1a-2 Hemoglobin
- Hemoglobin, Glycated A1a 2
Hemoglobin, Glycosylated A1a-1
- Hemoglobin, Glycosylated A1a-1
- A1a-1 Hemoglobin, Glycosylated
- Glycosylated A1a-1 Hemoglobin
- Hemoglobin, Glycosylated A1a 1
- Hb A1a-1
Hemoglobin, Glycated A1b
- Hemoglobin, Glycated A1b
- A1b Hemoglobin, Glycated
- Glycated A1b Hemoglobin
- Hb A1b
- Hemoglobin, Glycosylated A1b
- A1b Hemoglobin, Glycosylated
- Glycosylated A1b Hemoglobin
Glycated Hemoglobin A1c
- Glycated Hemoglobin A1c
- Hemoglobin A1c, Glycated
- Glycosylated Hemoglobin A1c
- Hemoglobin A1c, Glycosylated
- Glycated Hemoglobins
- Hemoglobins, Glycated
- Hemoglobin, Glycosylated
- Glycosylated Hemoglobin
Below are MeSH descriptors whose meaning is more general than "Glycated Hemoglobin A".
Below are MeSH descriptors whose meaning is more specific than "Glycated Hemoglobin A".
This graph shows the total number of publications written about "Glycated Hemoglobin A" by people in this website by year, and whether "Glycated Hemoglobin A" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Glycated Hemoglobin A" by people in Profiles.
Type 1 Diabetes Patients With Different Residual Beta-Cell Function but Similar Age, HBA1c, and Cardiorespiratory Fitness Have Differing Exercise-Induced Angiogenic Cell Mobilisation. Front Endocrinol (Lausanne). 2022; 13:797438.
Relationship between Arterial Stiffness and Subsequent Cardiac Structure and Function in Young Adults with Youth-Onset Type 2 Diabetes: Results from the TODAY Study. J Am Soc Echocardiogr. 2022 06; 35(6):620-628.e4.
Relationship between hemoglobin A1C and characteristics of plaque vulnerability in stable coronary disease: an optical coherence tomography study. Int J Cardiovasc Imaging. 2022 Feb; 38(2):473-482.
Risk factors associated with mortality in individuals with type 2 diabetes following an episode of severe hypoglycaemia. Results from a randomised controlled trial. Diab Vasc Dis Res. 2022 Jan-Feb; 19(1):14791641211067415.
Pulse consumption improves indices of glycemic control in adults with and without type 2 diabetes: a systematic review and meta-analysis of acute and long-term randomized controlled trials. Eur J Nutr. 2022 Mar; 61(2):809-824.
Reply: Percutaneous Coronary Intervention Outcomes According to HbA1c Levels. JACC Cardiovasc Interv. 2021 05 24; 14(10):1159-1160.
Estimated glucose disposal rate as a candidate biomarker for thrombotic biomarkers in T1D: a pooled analysis. J Endocrinol Invest. 2021 Nov; 44(11):2417-2426.
Hemoglobin A1c and Cardiovascular Outcomes Following Percutaneous Coronary Intervention: Insights From a Large Single-Center Registry. JACC Cardiovasc Interv. 2021 02 22; 14(4):388-397.
Accumulating Physical Activity in Short or Brief Bouts for Glycemic Control in Adults With Prediabetes and Diabetes. Can J Diabetes. 2020 Dec; 44(8):759-767.
Omega-3 polyunsaturated fatty acid supplementation versus placebo on vascular health, glycaemic control, and metabolic parameters in people with type 1 diabetes: a randomised controlled preliminary trial. Cardiovasc Diabetol. 2020 08 12; 19(1):127.